Cervical Cancer

Cervical cancer is a malignant condition that develops in the cells of the cervix, the lower part of the uterus connecting to the vagina. It is most commonly caused by persistent infection with high-risk types of Human Papillomavirus (HPV), a sexually transmitted virus. While HPV infection is common, cervical cancer usually develops slowly over several years, progressing from precancerous changes to invasive disease if left untreated.

In its early stages, cervical cancer may not produce noticeable symptoms, which makes regular screening essential. As the disease advances, symptoms may include abnormal vaginal bleeding, pelvic pain, pain during intercourse, and unusual vaginal discharge. Pap smear tests and HPV testing play a crucial role in early detection, significantly improving treatment outcomes.

Treatment for cervical cancer depends on the stage of the disease, patient’s age, and overall health. When diagnosed early, cervical cancer is highly treatable with a favorable prognosis.

Preventive strategies are central to reducing cervical cancer risk. HPV vaccination, safe sexual practices, and routine gynecological screenings are proven measures that help prevent the disease or detect it at a precancerous stage. Increased awareness, timely diagnosis, and access to appropriate medical care remain key to reducing cervical cancer-related morbidity and mortality.